TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares rose 2.56% to $2.00 on Monday, ending a two-day losing streak. However, the stock underperformed compared to competitors like AbbVie Inc., which gained 6.25%. Trading volume exceeded its 50-day average. Despite the daily gain, TXMD remains 32.20% below its 52-week high of $2.95 set in January.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) rose 2.56% to $2.00 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.29% to 51,712.71 and the NASDAQ Composite Index falling 1.32% to 26,166.60.
The stock's rise snapped a two-day losing streak.
TherapeuticsMD Inc. closed 32.20% below its 52-week high of $2.95, which the company achieved on January 27th.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) rose 6.25% to $230.01.
Trading volume (42,438) eclipsed its 50-day average volume of 39,628.
Data source: Dow Jones Market Data, FactSet. Data compiled June 22, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-22-26 1731ET